{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:04:47Z","timestamp":1780085087869,"version":"3.54.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,8,31]],"date-time":"2007-08-31T00:00:00Z","timestamp":1188518400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1007\/s10792-007-9131-0","type":"journal-article","created":{"date-parts":[[2007,8,30]],"date-time":"2007-08-30T06:57:50Z","timestamp":1188457070000},"page":"281-285","source":"Crossref","is-referenced-by-count":13,"title":["Rimexolone 1% versus prednisolone acetate in preventing early postoperative inflammation after cataract surgery"],"prefix":"10.1007","volume":"28","author":[{"given":"Sevim","family":"Kavuncu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Horoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aylin","family":"Ardagil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan H.","family":"Erbil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,8,31]]},"reference":[{"key":"9131_CR1","first-page":"78","volume":"79","author":"HM Leibowitz","year":"1975","unstructured":"Leibowitz HM, Kupferman A (1975) Bioavailability and therapeutic effectiveness of topically administered corticosteroids. Trans Am Acad Ophthalmol Otolaryngol 79:78\u201388","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"9131_CR2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00055735-200102000-00011","volume":"12","author":"JN Simone","year":"2001","unstructured":"Simone JN, Whitecare MM (2001) Effects of anti-inflammatory drugs following cataract extraction. Curr Opinion Ophthalmol 12:63\u201367","journal-title":"Curr Opinion Ophthalmol"},{"key":"9131_CR3","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/archopht.1996.01100140141005","volume":"116","author":"HM Leibowitz","year":"1996","unstructured":"Leibowitz HM, Bartlett JD, Rich R, McQuirter H, Steward R, Assil K (1996) Intraocular pressure-raising potential of 1% rimexolone in patients responding to corticosteroids. Arch Ophthalmol 116:933\u2013937","journal-title":"Arch Ophthalmol"},{"key":"9131_CR4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00055735-199902000-00006","volume":"10","author":"S Rowen","year":"1999","unstructured":"Rowen S (1999) Preoperative and postoperative medications used for cataract surgery. Curr Opin Ophthalmol 10:29\u201335","journal-title":"Curr Opin Ophthalmol"},{"key":"9131_CR5","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0886-3350(97)80286-6","volume":"23","author":"KK Assil","year":"1997","unstructured":"Assil KK, Massry G, Lehnmann R, Fox K, Stewart R (1997) Control of ocular inflammation after cataract extraction with rimexolone 1% ophthalmic suspension. J Cataract Refract Surg 23:750\u2013757","journal-title":"J Cataract Refract Surg"},{"key":"9131_CR6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/112067219800800105","volume":"8","author":"A Bron","year":"1996","unstructured":"Bron A, Hoang Xuan TC, Boureaux Andrieux C, Crozafon B, Hachet E, Medhorn E et al (1996) The effects of rimexolone 1% in postoperative inflammation after cataract extraction. A double-masked placebo-controlled study. Eur J Ophthalmol 8:16\u201321","journal-title":"Eur J Ophthalmol"},{"key":"9131_CR7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0002-9394(14)72008-2","volume":"122","author":"S Foster","year":"1996","unstructured":"Foster S, Alter G, DeBarge R, Raizman M, Crabb J, Santos C et al (1996) Efficacy and safety of rimexolone 1% ophthalmic suspension vs prednisolone acetate 1% in the treatment of uveitis. Am J Ophthalmol 122:171\u2013182","journal-title":"Am J Ophthalmol"},{"key":"9131_CR8","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1001\/archopht.1986.01050240043036","volume":"104","author":"WJ Stark","year":"1986","unstructured":"Stark WJ, Whithney CE, Chandler JW, Worthern DM (1986) Trends in intraocular lens implantation in the United States. Arch Ophthalmol 104:1769\u20131770","journal-title":"Arch Ophthalmol"},{"issue":"Suppl","key":"9131_CR9","first-page":"793","volume":"36","author":"R Lehnmann","year":"1995","unstructured":"Lehnmann R, Assil K, Stewart R, Fox K (1995) Comparison of rimexolone 1% ophthalmic suspension to placebo in control of postcataract surgery inflammation. Invest Ophthalmol Vis Sci 36(Suppl):793","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9131_CR10","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archopht.1963.00960050484010","volume":"70","author":"MF Armaly","year":"1963","unstructured":"Armaly MF (1963) Effects of corticosteroids on intraocular pressure and fluid dynamics 1. The effects of the dexametasone in the normal eye. Arch Ophthalmol 70:482\u2013491","journal-title":"Arch Ophthalmol"},{"key":"9131_CR11","first-page":"577","volume":"17","author":"S Ronen","year":"1985","unstructured":"Ronen S, Rozenman Y, Zylbermann R, Berson D (1985) Treatment of ocular inflammation with diclofenac sodium: double blind trial following cataract surgery. Ann Ophthalmol 17:577\u2013581","journal-title":"Ann Ophthalmol"},{"key":"9131_CR12","first-page":"198","volume":"4","author":"B Becker","year":"1965","unstructured":"Becker B (1965) Intraocular pressure response to topical corticosteroids. Invest Ophthalmol Vis Sci 4:198\u2013205","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9131_CR13","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1001\/archopht.121.12.1716","volume":"121","author":"DPS Fan","year":"2003","unstructured":"Fan DPS, Yu OBG, Chiu TYH, Wong YC, Ng JSK et al (2003) Ocular hypertensive and anti-inflammatory response to rimexolone therapy in children. Arch Ophthalmol 121:1716\u20131721","journal-title":"Arch Ophthalmol"},{"key":"9131_CR14","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00055735-200012000-00016","volume":"11","author":"MC Carnahan","year":"2000","unstructured":"Carnahan MC, Goldstein DA (2000) Ocular complications of topical, periocular and systemic corticosteroids. Curr Opinion Ophthal 11:478\u2013483","journal-title":"Curr Opinion Ophthal"},{"issue":"8","key":"9131_CR15","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s00417-005-1126-9","volume":"243","author":"C Hirneiss","year":"2005","unstructured":"Hirneiss C, Neubauer AS, Kampik A, Schonfeld CL (2005) Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study. Graefes Arch Clin Exp Ophthalmol 243(8):768\u2013773","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"9131_CR16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10792-004-5195-2","volume":"25","author":"J Biswas","year":"2004","unstructured":"Biswas J, Ganeshbabu TM, Raghevenderan SR, Raizada S, Mondkar SV, Madhavan HN (2004) Efficacy and safety of 1% rimexolone versus 1% prednisolone acetate in the treatment of anterior uveitis a randomized triple masked study. Int Ophthalmol 25(3):147\u2013153","journal-title":"Int Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-007-9131-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-007-9131-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-007-9131-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:24:10Z","timestamp":1559262250000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-007-9131-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,31]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["9131"],"URL":"https:\/\/doi.org\/10.1007\/s10792-007-9131-0","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,31]]}}}